Brief: Infant Bacterial Therapeutics AB Operating Profit at SEK 1.3 MLN
16/08/2018 07:08
Aug 16 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST :
* Q2 NET SALES 0 KSEK (121)
* Q2 OPERATING PROFIT 1 286 KSEK (-13 826)
Source text for Eikon: ID:nGNEbGLD2P
Further company coverage: IBTb.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln